Aderico Medical Ltd 14372946 false 2022-09-23 2023-09-30 2023-09-30 The principal activity of the company is Management consultancy Digita Accounts Production Advanced 6.30.9574.0 true 14372946 2022-09-23 2023-09-30 14372946 2023-09-30 14372946 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 14372946 bus:Micro-entities 2022-09-23 2023-09-30 14372946 bus:AuditExemptWithAccountantsReport 2022-09-23 2023-09-30 14372946 bus:FullAccounts 2022-09-23 2023-09-30 14372946 bus:SmallCompaniesRegimeForAccounts 2022-09-23 2023-09-30 14372946 bus:RegisteredOffice 2022-09-23 2023-09-30 14372946 bus:Director2 2022-09-23 2023-09-30 14372946 bus:PrivateLimitedCompanyLtd 2022-09-23 2023-09-30 14372946 countries:UnitedKingdom 2022-09-23 2023-09-30 iso4217:GBP xbrli:pure

Registration number: 14372946

Aderico Medical Ltd

Unaudited Filleted Financial Statements

for the Period from 23 September 2022 to 30 September 2023

 

Aderico Medical Ltd

Contents

Balance Sheet

1

 

Aderico Medical Ltd

(Registration number: 14372946)
Balance Sheet as at 30 September 2023

2023
£

Fixed assets

431

Current assets

5,110

Creditors: Amounts falling due within one year

(2,648)

Net current assets

2,462

 

2,893

Capital and reserves

2,893

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Suite 2 Healey House
Dene Road
Andover
Hampshire
SP10 2AA

These financial statements were authorised for issue by the Board on 21 February 2024.

The average number of persons employed by the company (including directors) during the period, was 1.

For the financial period ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 21 February 2024 and signed on its behalf by:
 

.........................................
T L Potter
Director